About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Racial Differences in Oral Anticoagulant Usage

by Ramya Rachamanti on November 29, 2018 at 2:23 PM
Font : A-A+

 Racial Differences in Oral Anticoagulant Usage

White and Hispanic patients are receiving novel and powerful oral anticoagulants when compared to black patients with atrial fibrillation, according to a new study published in JAMA Cardiology.

First author Utibe R. Essien, M.D., M.P.H., assistant professor in the University of Pittsburgh Division of General Internal Medicine, used the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II registry (ORBIT-AF II) to source patient data for the study.

Advertisement


He conducted the research during his fellowship at Massachusetts General Hospital. Registry data for 11,100 white patients, 646 black patients and 671 Hispanic patients with atrial fibrillation collected from February 2013 through June 2016 was included in the analysis.

After controlling for clinical and sociodemographic factors, black patients had 25 percent lower odds of receiving any oral anticoagulant drugs compared to their white and Hispanic counterparts, and 37 percent lower odds of receiving the easier to use and likely safer direct-acting oral anticoagulants. There was no difference in prescriptions between whites and Hispanics.
Advertisement

"For patients with atrial fibrillation, long-term oral anticoagulant use can reduce their risk of stroke. Even after our analysis adjusted for socioeconomic factors, black patients were still less likely to receive these types of drugs," said Essien.

"Blacks with atrial fibrillation are already at a higher risk of complications, so improving health literacy and reducing disparities related to medication use could help improve their overall quality of care and reduce complications."

Many factors, including limited access to specialists, out-of-pocket costs, medication adherence and implicit bias, have been suggested as possible reasons for the disparities in care for patients with atrial fibrillation, but further research is needed to address and correct these issues.



Source: Eurekalert
Advertisement
Advertisement
Advertisement

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Racial Differences in Oral Anticoagulant Usage Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests